Market open
Enzo Biochem/$ENZ
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Enzo Biochem
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.
Ticker
$ENZ
Sector
Trading on
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
131
Website
Enzo Biochem Metrics
BasicAdvanced
$38M
Market cap
-
P/E ratio
-$0.45
EPS
0.73
Beta
$0.10
Dividend rate
54.95%
Dividend yield
Price and volume
Market cap
$38M
Beta
0.73
52-week high
$1.50
52-week low
$0.68
Average daily volume
199K
Dividend rate
$0.10
Financial strength
Current ratio
2.55
Quick ratio
2.204
Long term debt to equity
4.96
Total debt to equity
6.855
Interest coverage (TTM)
-52.35%
Management effectiveness
Return on assets (TTM)
-7.24%
Return on equity (TTM)
-11.83%
Valuation
Price to revenue (TTM)
1.235
Price to book
0.8
Price to tangible book (TTM)
0.8
Price to free cash flow (TTM)
-1.655
Dividend yield (TTM)
13.74%
Forward dividend yield
54.95%
Growth
Revenue change (TTM)
-4.57%
Earnings per share change (TTM)
-191.65%
3-year revenue growth (CAGR)
-35.99%
3-year earnings per share growth (CAGR)
65.27%
Enzo Biochem Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Enzo Biochem Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Enzo Biochem News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Enzo Biochem stock?
Enzo Biochem (ENZ) has a market cap of $38M as of December 30, 2024.
What is the P/E ratio for Enzo Biochem stock?
The price to earnings (P/E) ratio for Enzo Biochem (ENZ) stock is 0 as of December 30, 2024.
Does Enzo Biochem stock pay dividends?
Yes, the Enzo Biochem (ENZ) stock pays dividends to shareholders. As of December 30, 2024, the dividend rate is $0.1 and the yield is 54.95%. Enzo Biochem has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Enzo Biochem dividend payment date?
The next Enzo Biochem (ENZ) dividend payment date is unconfirmed.
What is the beta indicator for Enzo Biochem?
Enzo Biochem (ENZ) has a beta rating of 0.73. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.